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Voiding Dysfunction
Transobturator Tape Operation Is More Effective in Premenopausal 
Women than in Postmenopausal Women with Stress Incontinence
Polat Dursun, Tevfik Berk Bildaci, Hulusi Bulent Zeyneloglu, Esra Kuscu, Ali Ayhan
Department of Obstetrics and Gynecology, Baskent University School of Medicine, Ankara, Turkey
Purpose: Midurethral synthetic slings for female stress urinary incontinence are mini-
mally invasive polypropylene mesh tapes that are inserted under the midurethra with 
trocars. In the past decade, this new technology has become the most commonly per-
formed procedure for female stress urinary incontinence, replacing the traditional open 
procedures. However, its effectiveness in pre- and postmenopausal women has not pre-
viously been compared.
Materials and Methods: We assessed the clinical outcome of the transobturator tape 
(TOT) procedure in premenopausal (n=45) and postmenopausal (n=49) women by 
means of self-report and the Urinary Distress Inventory 6 (UDI-6) questionnaire.
Results: The mean age of the pre- and postmenopausal women was 44 and 60 years, 
respectively. Mean parity was 2.4 and 3, respectively. There were no significant differ-
ences with respect to mean operation time, duration of hospitalization, or intra-
operative and postoperative complications. However, premenopausal women were 
more satisfied with the operation than were postmenopausal women (p=0.014). Also, 
UDI-6 scores were significantly better in premenopausal women (p=0.027).
Conclusions: The TOT operation appeared to be more effective in premenopausal wom-
en with stress urinary incontinence. However, further studies with larger sample sizes 
are needed to confirm our results.
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INTRODUCTION
Stress urinary incontinence (SUI) is defined as the in-
voluntary leakage of urine on effort, exertion, or coughing 
[1]. The reported prevalence of SUI is variable, but several 
studies have suggested that it may be as high as one in four 
adult women [2].  SUI in most cases is caused by loss of ure-
thral support, resulting in hypermobility and lower pres-
sure transmission to the urethra than the bladder, which 
is surgically curable. 
In the past decade, midurethral synthetic slings like the 
transobturator tape (TOT) have become the most popular 
procedure for female SUI. Although many other different 
surgical procedures (colposuspension, traditional slings, 
and injectables) are commonly used, these procedures are 
associated with significant morbidity and resource use or 
low success rates. 
It is now well demonstrated that the urogenital organs 
are highly sensitive to the influence of estrogen. In fact, es-
trogen receptors have been found in the urethra and blad-
der trigone as well as in the round ligaments and levator 
ani muscles [3,4]. Following those findings, the idea arose 
of a possible relation between SUI and the causes of de-
creased estrogen status, such as menopause. Although SUI 
increases in parallel to age, number of vaginal deliveries, 
and menopausal status, it is known that it can be seen in 
young premenopausal women as well. The TOT procedure 
may therefore also be a valid alternative for these young 
patients.  
In this study, we aimed to summarize our experience Korean J Urol 2011;52:612-615
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TABLE 1. Type of operations performed
Type of operation 
performed
Menopausal status
Premenopausal Postmenopausal
Transobturator tape (%)
Transobturator tape+ 
  colporrhaphy anterior and 
  posterior (%)
Transobturator tape+
  hysterectomy (%)
Transobturator tape+other
  operations (%)
  9 (20)
18 (40)
   15 (33.3)
   3 (6.7)
22 (44.9)
10 (20.4)
15 (30.6)
2 (4.1)
Percentages are described within the group of their own meno-
pausal status.
TABLE 2. UDI-6 scores in pre- and postmenopausal patients 
Difference between 
total scores on the UDI-6 
before and after
Menopausal state
Premenopausal Postmenopausal
Group A ‘getting better’ 
  (Very satisfied or 
  satisfied) (%)
Group B ‘worsening situ-
  ation’ (Not satisfied or very
  much not satisfied) (%)
14 (77.8)
  4 (22.2)
12 (44.4)
15 (55.6)
Difference between the two groups was statistically significant 
(p=0.027). Given percentages calculated within groups.
with the TOT procedure and its outcome for a mean period 
of 42 months by use of the Urinary Distress Inventory 6 
(UDI-6). We also compared the effectiveness of the TOT op-
eration between the premenopausal and postmenopausal 
women. To the best of our knowledge, the effectiveness of 
the TOT procedure has not previously been compared in 
pre- and postmenopausal women.
MATERIALS AND METHODS
Patients operated on consecutively between 2004 and 2010 
were analyzed in this retrospective study. Ninety-four pa-
tients who complained of SUI and had other uro-gyneco-
logic complaints including different kinds of pelvic relaxa-
tion were subjected to different kinds of operations includ-
ing the TOT procedure alone and other operations com-
bined with the TOT procedure. Patients found to have other 
kinds of incontinence (urge or mixed) and patients who had 
symptoms of overactive bladder were not subjected to the 
TOT procedure. Patients’ demographic variables such as 
age, menopausal status, gravida, parity, and operative in-
formation such as the type of operations, duration of oper-
ations and hospitalizations, and type of complications were 
extracted from the patients’ files and hospital records. All 
TOT procedures were performed in the outside-in manner 
as described previously by Delorme [5].
The UDI-6 questionnaire was administered at the time 
of surgery and a mean period of 42.6 months (range, 5 to 
72 months) for menopausal patients and 41.9 months 
(range, 5-76 months) for premenopausal patients after sur-
gery (p=0.886). A self-evaluation of the level of satisfaction 
was also performed. To assess the rate of satisfaction from 
the patients’ own perspective, the patients were asked a 
clear question during the interview of whether they were 
pleased and satisfied with the results of the operation. 
Answers were noted individually for every patient. The 
statistical analyses were performed by using SPSS ver. 
17.0 (SPSS Inc., Chicago, IL, USA). Chi-square, one way 
ANOVAs, and Student's t test were used where appro-
priate. A p-value of 0.05 was used to express the statistical 
significance.  
RESULTS
The mean age of the whole study group was 52 years (range, 
28 to 86 years).  There were 44 (46.8%) premenopausal and 
50 (53.2%) postmenopausal patients in each group, 
respectively. The mean age of the pre- and postmenopausal 
women was 43 years (range, 26 to 54 years) and 60 years 
(range, 47 to 86 years), respectively. Mean parity was 2.7. 
Parity for pre- and postmenopausal women was 2.4 and 3, 
respectively (p=0.047). Women who had vaginal deliveries 
only were included in the study. Mean body mass index was 
27.5 and 28.9 for pre- and postmenopausal women, re-
spectively (p=0.20). None of the postmenopausal patients 
were using any type of hormone replacement therapy. 
Although systemic anesthesia was used for 33 (35.1%) pa-
tients, regional anesthesia was the choice for 61 (64.9%) 
patients. Comorbid disease was found in 66% of patients. 
The most frequent comorbid illness was hypertension 
(33.2%). The mean operation time was 97 and 78 minutes 
for premenopausal and postmenopausal patients, re-
spectively (operation time for accompanying procedure 
was also included). Mean urinary catheterization time was 
30 hours for premenopausal and 38 hours for post-
menopausal patients. TOT was used as a single procedure 
for 31 patients (33%). Other gynecologic operations per-
formed with the TOT procedure are described in Table 1. 
Of the 94 patients, 1 had prolonged bleeding during the 
operation, 1 patient had infection at the operation site, 2 
had urinary retention subsequent to TOT and colpor-
rhaphy anterior and posterior operation, and 2 patients un-
derwent a repeat operation owing to material erosion dur-
ing this time period.     
Using the UDI-6 questionnaire, we created two groups 
according to the difference between the total score for the 
questionnaire before and after the operations. Group A was 
defined as “getting better,” meaning that the patients were 
satisfied or very satisfied. By the same logic, group B stood 
for “worsening situation,” meaning that the patients were 
not satisfied or very much not satisfied. Table 2 shows the 
difference in UDI-6 scores between the pre- and post-
menopausal patients. Table 3 displays the difference be-
tween the premenopausal and postmenopausal patients in Korean J Urol 2011;52:612-615
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TABLE 3. Patients’ self-evaluation of the level of satisfaction
Degree of satisfaction
Menopausal status
Premenopausal Postmenopausal
Either very satisfied or
  satisfied (%)
Neither satisfied nor
  dissatisfied (%)
Either not satisfied or very 
  much not satisfied (%)
12 (66.7)
  5 (27.8)
1 (5.6)
  8 (29.6)
  8 (29.6)
11 (40.7)
Difference between the three groups was statistically significant
(p=0.004).
satisfaction with the operations from the patients’ 
perspective. 
DISCUSSION
SUI has been shown to cause deterioration in quality of life, 
poor care seeking, lifestyle restriction, limitations in social 
relationships, and a higher prevalence of psychological 
morbidity in both the pre- and postmenopausal periods [6]. 
The main pathophysiologic process is thought to be the loss 
of urethral support with advancing age and with increasing 
parity. This support can be regained by surgical inter-
ventions such as TOT.  Two kinds of techniques have been 
described by two different authors. Delorme introduced the 
out-to-in manner in 2001 [5]; on the other hand, in 2003 de 
Leval came up with the in-to-out technique for trans-
obturator placement of the polypropylene mesh [7]. We 
used the technique described by de Leval et al and we en-
countered no surgery-related complications. Debodinance 
found comparable efficacy and safety profiles for the out-
side-in and the inside-out procedures [8].
Multiple factors can be named as causes for pelvic relaxa-
tion and as a result for SUI. Gürel and Gürel found that age, 
marriage period, and parity are directly and strongly re-
lated to pelvic relaxation [9]. Other histopathological 
changes such as milder positivity of collagen stains, dis-
tribution of collagen stains in unequal intensities, and 
atrophy of the collagen fibers were reported previously by 
Luo et al [10].  On the other hand, it is well known that the 
prevalence of SUI increases with aging in women owing to 
menopause and the loss of estrogen. Furthermore, it was 
recently shown that the menopausal transition stage is 
strongly associated with developing monthly or more fre-
quent incontinence in women [11]. However, to the best of 
our knowledge, the effect of menopausal status on the suc-
cess of TOT operations has not been investigated properly. 
On the other hand, the effect of menopause on the success 
and failure rate of the Burch operation was described pre-
viously by Sun et al They studied the Burch operation in 
258 patients and noted that age, parity, menopausal sta-
tus, and use of hormone replacement therapy had no effect 
on the failure rate [12]. Like the report previously noted, 
Akpinar et al also reported that menopause had no effect 
on the long-term outcome of the Burch operation [13]. On 
the other hand, Langer et al investigated the clinical and 
urodynamic short-term results after colposuspension for 
urinary stress incontinence in a group of young patients in 
whom menopause was induced surgically and compared 
these results with those of a similarly treated group who 
did not undergo surgical castration. They found that surgi-
cally induced menopause in the absence of aging had no ef-
fect on the results of colposuspension for urinary stress in-
continence in the short term [14].
The only study that investigated the relationship be-
tween the success of TOT operations and menopause was 
reported in 2010 by Rechberger et al Those authors found 
that the clinical effectiveness of surgical SUI treatment did 
not depend on the patient’s body mass index or type of mid-
urethral sling, but that menopausal status and aging sig-
nificantly influenced the outcome of the surgery. They also 
concluded that both menopause and aging had a detri-
mental influence on the final outcome of both the retro-
pubic and transobturator sling procedure. In our study, we 
confirmed the results of Rechberger et al [15]. 
It is well known that estrogen and progesterone re-
ceptors have been found throughout the lower urinary tract 
[16], and many of the tissues involved in female continence 
have been found to be estrogen-sensitive, such as the ure-
thra and bladder. Because estrogens are also known to 
have an effect on the synthesis of collagen and the metabo-
lism of collagen in the lower genital tract, the significant 
difference that we found between pre- and postmenopausal 
patients is likely related to the loss of estrogen support of 
urogenital tissues [17]. Animal models have indicated that 
estrogen significantly decreases the amount of collagen fi-
bers, increases the amount of muscle fibers in the detrusor 
muscle, and therefore decreases the collagen/smooth mus-
cle ratio in the detrusor muscle and in the urethral muscle 
layer [18]. Rud et al concluded that the vascular network 
of the urethra plays an important role in the maintenance 
of urinary continence, accounting for one-third of urethral 
pressure [19]. These findings from the studies mentioned 
support both our hypothesis and the estrogen effect on the 
urethra and bladder, which leads to loosening of the pelvic 
tissues with the loss of estrogen in postmenopausal women. 
In the present study, we found that the TOT procedure is 
more beneficial for premenopausal patients.  
Our study did have some drawbacks, such as the lack of 
urodynamic evaluation of the patients both before and af-
ter the operation and the fact that concomitant operations 
were performed with TOT. In conclusion, the TOT proce-
dure appears to be more effective in premenopausal women 
with SUI. However, further prospective studies using pre- 
and postoperative urodynamic evaluations are needed to 
confirm our results.
Conflicts of Interest
The authors have nothing to disclose.Korean J Urol 2011;52:612-615
TOT in Premenopausal Women 615
REFERENCES
1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, 
et al. The standardisation of terminology of lower urinary tract 
function: report from the Standardisation Sub-committee of the 
International Continence Society. Am J Obstet Gynecol 2002; 
187:116-26.
2. Atherton MJ, Stanton SL. The tension-free vaginal tape re-
viewed: an evidence-based review from inception to current. 
BJOG 2005;112:534-46.
3. Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human 
female lower urinary tract. Am J Obstet Gynecol 1981;141: 
817-20.
4. Smith P. Estrogens and the urogenital tract. Studies on steroid 
hormone receptors and clinical study on a new estradiol-releasing 
vaginal ring. Acta Obstet Gynecol Scand Suppl 1993;157:1-26.
5. Delorme E. Transobturator urethral suspension: mini-invasive 
procedure in the treatment of stress urinary incontinence in 
women. Prog Urol 2001;11:1306-13.
6. Kane AR, Nager CW. Midurethral slings for stress urinary 
incontinence. Clin Obstet Gynecol 2008;51:124-35.
7. de Leval J. Novel surgical technique for the treatment of female 
stress urinary incontinence: transobturator vaginal tape in-
side-out. Eur Urol 2003;44:724-30.
8. Debodinance P. Trans-obturator urethral sling for the surgical 
correction of female stress urinary incontinence: outside-in 
(Monarc) versus inside-out (TVT-O) Are the two ways reassur-
ing? Eur J Obstet Gynecol Reprod Biol 2007;133:232-8.
9. Gürel H, Gürel SA. Pelvic relaxation and associated risk factors: 
the results of logistic regression analysis. Acta Obstet Gynecol 
Scand 1999;78:290-3.
10. Luo X, Shuai HL, Wang XY, Jiang XF, Xie JY. Changes of collagen 
content in uterine ligaments of perimenopausal women with re-
laxation of pelvic supports. Zhonghua Fu Chan Ke Za Zhi 
2008;43:422-4.
11. Waetjen LE, Ye J, Feng WY, Johnson WO, Greendale GA, 
Sampselle CM, et al. Association between menopausal transition 
stages and developing urinary incontinence. Obstet Gynecol 
2009;114:989-98.
12. Sun MJ, Ng SC, Tsui KP, Chang NE, Lin KC, Chen GD. Are there 
any predictors for failed Burch colposuspension? Taiwan J Obstet 
Gynecol 2006;45:33-8.
13. Akpinar H, Cetinel B, Demirkesen O, Tufek I, Yaycioglu O, Solok 
V. Long-term results of Burch colposuspension. Int J Urol 
2000;7:119-25.
14. Langer R, Golan A, Arad D, Pansky M, Bukovsky I, Caspi E. 
Effects of induced menopause on Burch colposuspension for uri-
nary stress incontinence. J Reprod Med 1992;37:956-8.
15. Rechberger T, Futyma K, Jankiewicz K, Adamiak A, Bogusiewicz 
M, Skorupski P.  Body mass index does not influence the outcome 
of anti-incontinence surgery among women whereas menopausal 
status and ageing do: a randomised trial. Int Urogynecol J 
2010;21:801-6.
16. Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human 
female lower urinary tract. Am J Obstet Gynecol 1981;141: 
817-20.
17. Robinson D, Cardozo LD. The role of estrogens in female lower 
urinary tract dysfunction. Urology 2003;62(4 Suppl 1):45-51.
18. Sartori MG, Girão MJ, de Jesus Simões M, Sartori JP, Baracat 
EC, Rodrigues de Lima G. Quantitative evaluation of collagen and 
muscle fibers in the lower urinary tract of castrated and un-
der-hormone replacement female rats. Clin Exp Obstet Gynecol 
2001;28:92-6.
19. Rud T, Andersson KE, Asmussen M, Hunting A, Ulmsten U. 
Factors maintaining the intraurethral pressure in women. Invest 
Urol 1980;17:343-7.